Biomarkers and Associated Outcomes in Patients With Pneumonia

Chongqing Medical University1 个研究点分布在 1 个国家目标入组 272 人2018年1月1日

适应症Pneumonia

概览

阶段: 不适用
干预措施: 未指定
疾病 / 适应症: Pneumonia
发起方: Chongqing Medical University
入组人数: 272
试验地点: 1
主要终点: mortality
状态: 已完成
最后更新: 上个月

概览研究者入排标准结局指标研究点相似试验

概览

简要总结

To identifying biomarkers in patients with pneumonia

详细描述

The aim of this study is to identify the biomarkers in patients with pneumonia. These biomarkers can distinguish community-acquired pneumonia, hospital-acquired pneumonia, severe pneumonia, bacterial infection, virus infection and fungal infection. Furthermore, these biomarkers can identify the efficacy of treatment in patients with different interventions.

注册库

clinicaltrials.gov

开始日期

2018年1月1日

结束日期

2025年12月31日

最后更新

上个月

研究类型

Observational

性别

All

研究者

发起方

Chongqing Medical University

责任方

Principal Investigator

主要研究者

Duan jun

Clinical Professor

Chongqing Medical University

入排标准

入选标准

•Healthy patients without any diseases -

排除标准

•Age less than 18 years

结局指标

主要结局

mortality

时间窗: From diagnosis of pneumonia to discharge from hospital or up to 90 days, whichever came first

Mortality is defined the patient died in hospital.

次要结局

severe pneumonia(From diagnosis of pneumonia to discharge from hospital or up to 90 days, whichever came first)
initial treatment failure(From diagnosis of pneumonia to discharge from hospital or up to 90 days, whichever came first)